Climate Change Data

Carbiotix AB

Climate Impact & Sustainability Data (2019, 2020-01 to 2020-03, 2021-01-01 to 2023-09-30)

Reporting Period: 2019

Environmental Metrics

Social Achievements

  • Launched second-generation diagnostic platform for gut health.
  • Entered into collaborations with Gebro Pharma, FoodMarble, and the University of Verona for research and pilot studies.

Governance Achievements

  • Listed on Spotlight Stock Market.

Climate Goals & Targets

Medium-term Goals:
  • Launch medical food containing AXOS in H2 2021.
Short-term Goals:
  • Achieve market approval in the US for AXOS in 2020.

Environmental Challenges

  • The significantly worsened market situation as a result of COVID-19 created significant uncertainty regarding customers' ability to engage in projects related to the company's products and pharmaceuticals in the short term. This was expected to lead to a slowdown in the pace of development, resulting in an extension of the time horizon until commercial success.
Mitigation Strategies
  • In late March 2020, the Carbiotix board decided to implement measures to adapt the organization to the new circumstances. The specific measures included staff reductions, reduced consulting assignments, and other reduced costs.

Supply Chain Management

Climate-Related Risks & Opportunities

Sustainable Products & Innovation

  • Carbiotix AXOS, a prebiotic soluble fiber

Awards & Recognition

  • Accepted as a member of the Global Prebiotic Association

Reporting Period: 2020-01 to 2020-03

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Not disclosed

Environmental Achievements

  • Not disclosed

Social Achievements

  • Dr. Jan Marsal joined the Advisory Board to support the development of medical food and therapeutic applications.
  • Henrik Ljung appointed as CFO to support accelerated growth.

Governance Achievements

  • Not disclosed

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Not disclosed
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Not disclosed
Mitigation Strategies
  • Not disclosed

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed

Reporting Period: 2021-01-01 to 2023-09-30

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Not disclosed

Environmental Achievements

  • Improved CarbiAXOS production process reducing the need for chemicals, shortening production time, and minimizing environmental impact.

Social Achievements

  • Not disclosed

Governance Achievements

  • Not disclosed

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Complete the Novel Foods process for CarbiAXOS based on corn fibers and start sales of CarbiAXOS for dietary supplement applications within the EU.
  • Identify a European contract manufacturing partner to support faster scaling, and expand the production facility in Bjuv to meet growing demand for both cosmetic and dietary supplement ingredients.
  • Continue to increase sales of CarbiAXOS for dietary supplement applications in the US and evaluate the need for a Carbiotix production facility in the US.
  • Complete the expanded CarbiAXOS Metformin study and secure at least one combination therapy partner and continued studies in other indication areas.
Short-term Goals:
  • Complete the ongoing CarbiAXOS Metformin study for type 2 diabetes patients and submit an EU funding application to expand this study to several hundred patients.
  • Increase production of samples from Bjuv for various internal and external safety, efficacy, and validation tests for dietary supplement and cosmetic applications.
  • Submit the first patent application for CarbiAXOS as an advanced synbiotic product.
  • Submit a Novel Foods application allowing the sale of CarbiAXOS in Europe as a dietary supplement ingredient.
  • Upgrade the production facility in Bjuv with a spray dryer to expand the production capacity of CarbiAXOS and become less dependent on third parties.
  • Begin sales of CarbiAXOS cosmetic ingredients globally and thus production at the facility in Bjuv to meet growing demand.
  • Begin sales of CarbiAXOS for dietary supplement applications in the US through the US contract manufacturing partner via direct sales, trade shows, and suitable distribution networks/partners.
  • Complete validation tests of CarbiAXOS based on recycled oat and pea fibers, and conduct the GRAS SA process for at least one of these fibers.

Environmental Challenges

  • Unforeseeable delays in the GRAS SA approval process due to third-party process enzyme issues.
  • Limited existing working capital to sustain operations for 12 months.
Mitigation Strategies
  • Developed a new, improved CarbiAXOS production process that is enzyme-independent, uses fewer chemicals and less energy, and yields a higher-quality product.
  • Conducting a rights issue to raise capital.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Not disclosed

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • Not disclosed

Not disclosed

Sustainable Products & Innovation

  • CarbiAXOS, a prebiotic fiber produced from non-GMO corn fiber extract, with plans to expand to oat and pea fibers.

Awards & Recognition

  • Not disclosed